Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Women associated with CervicalCheck group refused treatment by clinicians as one claims she was 'treated like a leper'

One woman described being 'treated like a leper' after she was questioned by a clinician about any association with the 221+ group

Irish Mirror

Measles now an imminent global threat due to pandemic, say WHO and CDC

There is now an imminent threat of measles spreading in various regions globally, as COVID-19 led to a steady decline in vaccination coverage and weakened surveillance of the disease, the World Health Organization (WHO) and the U.S. public health agency said on Wednesday.

Reuters

Mirati Therapeutics Surges As Big Pharma Reportedly Preps For A Buyout Battle

Big Pharma suitors could be looking to buy Mirati Therapeutics, according to reports that sent MRTX stock close to a breakout Wednesday.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

WHO, CDC: A record 40 million kids miss measles vaccine dose

The World Health Organization and the U.S. Centers for Disease Control and Prevention say measles immunization has dropped significantly since the coronavirus pandemic began, resulting in a record high of nearly 40 million children missing a vaccine dose last year

The Independent UK

Record number of children miss measles vaccine: global report

Washington (AFP) - A record high of nearly 40 million children around the world missed a measles vaccine dose in 2021, according to a new report Wednesday that found immunization levels had failed to rebound from disruptions caused by the Covid-19 pandemic.

AFP

Revealed: Tory peer Michelle Mone secretly received £29m from ‘VIP lane’ PPE firm

Documents suggest husband passed on money from PPE Medpro, which secured £200m contracts after Mone lobbied ministers

The Guardian - UK

What are the key moments from the South African President’s visit to the UK?

Here are some of the key moments from the last two days, as the South African President’s visit to the UK continues.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Is This Biotech Stock a Buy for Under $3?

Biotech company Bionano Genomics (BNGO) has beaten analysts’ top-line estimate in the third quarter. However, its cash and cash equivalents balance has declined year-over-year. Therefore, is it a buy now under $3? Read on to find out….

StockNews.com

California’s ‘tripledemic’ of viruses is on the rise. Here’s how to care for a sick loved one

Trying to avert a heavy surge in respiratory illnesses, California’s leading public health officials once again stressed on Tuesday that state residents should do all they can to prevent the spread of COVID-19, the flu and respiratory syncytial virus, or RSV, as they gather for the holidays.

Tribune News Service

Scale of drugs problem contributes to existence of paramilitary groups, MPs told

"The harms of paramilitarism are much broader and will need a tailored and very different process."

Belfast Live

Gene therapy at $3.5m a dose approved for US adults with hemophilia B

Hemgenix frees patients from repeated treatments but initial cost makes it most expensive medicine in the world

The Guardian - US

The FDA Just Approved Its Most Expensive Drug Ever — Sending UniQure Stock On A Warpath

The FDA just approved its most expensive drug ever — a hemophilia gene therapy from CSL and UniQure — and QURE stock popped Wednesday.

Investors Business Daily

China's Zhengzhou, Shenyang to tighten COVID rules

Eight districts in the central Chinese city of Zhengzhou will conduct mass COVID-19 testing for five consecutive days from Nov. 25, state television CCTV reported on Wednesday.

Reuters

As STDs proliferate, companies rush to market at-home test kits. But are they reliable?

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

Tribune News Service

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

1 Stock to Buy Now That Could Make You Rich in 2023

Biopharmaceutical major Bristol-Myers Squibb Company (BMY) beat the consensus earnings and revenue estimates in the third quarter. Given its strong product pipeline, strategic acquisitions, discounted valuation, high profitability, strong financials, and attractive dividends, investors could buy the stock now. Read more….

Investors Business Daily

See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch

Gilead Sciences' first-in-class cancer drug and GILD stock are finally hitting their stride. The oncology business is growing bullishly.

Reuters

Britain and South Africa agree health partnership on second day of state visit

Britain and South Africa on Wednesday announced a new health and science partnership to mark the second day of President Cyril Ramaphosa's state visit to London, the first such official guest hosted by Britain's King Charles.

The Independent UK

UK and South Africa to strengthen health and climate partnership

The two nations signed an agreement during South African President Cyril Ramaphosa’s state visit to the UK.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Japan News/Yomiuri

COVID pill approval ups pandemic arsenal

The health ministry has granted emergency approval for a COVID-19 pill developed by Shionogi Co., opening the door for Japan's first domestically produced oral medicine for the virus to become available as soon as early December.

Axios

The growing menopause-at-work market

Little discussed and poorly understood, menopause — and the market for helping treat its accompanying symptoms — is gaining more attention when it comes to employer benefits.

The Independent UK

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

Wales Online

New clinical trial will test whether infections need antibiotics

At present, medics may sometimes give out antibiotics unnecessarily because it is not clear whether an infection is caused by bacteria

ABC News

Medical device companies upselling products to surgeons in operating theatres, insider claims

A former marketing manager for medical device companies says company reps would go into operating theatres ostensibly to give surgeons technical support, but with the prime aim of selling more products.

The Independent UK

$3.5M gene therapy for hemophilia gets FDA approval

U.S. health regulators have approved the first gene therapy for hemophilia, a blood-clotting disorder with few treatment options

Tribune News Service

New booster shots cut risk of symptomatic COVID-19

WASHINGTON — The new bivalent COVID-19 booster shots are up to 56% more effective at preventing symptomatic COVID-19 infection than the two original COVID-19 vaccines in adults ages 18 and up, according to new data from the Centers for Disease Control and Prevention.

1 … 88 89 90 91

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.